Point State Capital LP Astrazeneca PLC Transaction History

Point State Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $3.99 Million - $4.79 Million	67,349 Added 100.0%	134,698 $8.9 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $44.7 Million - $53.7 Million	-754,550 Reduced 91.81%	67,349 $4.45 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $8.53 Million - $9.33 Million	153,509 Added 22.97%	821,899 $49.4 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $9.72 Million - $12.1 Million	-200,823 Reduced 23.1%	668,390 $40 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $34.6 Million - $40 Million	734,213 Added 543.86%	869,213 $43.2 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $6.55 Million - $7.83 Million	135,000 New	135,000 $6.75 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $9.93 Million - $10.6 Million	-287,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $9.47 Million - $10.5 Million	287,300 New	287,300 $10 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.